Organization
Austin Hospital
4 abstracts
Abstract
AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).Org: NHMRC Clinical Trial Centre, Shoalhaven District Memorial Hospital, Flinders Medical Centre, Australasian Gastro-Intestinal Trials Group, Sunshine Hospital,
Abstract
Efficacy and safety of sunvozertinib in treatment naïve NSCLC patients with EGFR exon20 insertion mutations.Org: Peking Union Medical College Hospital, Academy of Medical Sciences & Peking Union Medical College, Beijing, China, National Taiwan University Hospital Yunlin Branch, National Taiwan University Cancer Center/Hospital, Taipei Veterans General Hospital, Chang Gung Memorial Hospital at Linkou and Chang Gung University,
Abstract
Capability evaluation of a large regional clinical trials unit to assess growth over time.Org: Ballarat Regional Integrated Cancer Centre, Ballarat Health Services, Grampians Health, Austin Hospital,
Abstract
Association of common inherited NOD2 mutations with exceptional response to immune checkpoint inhibitors.Org: Garvan Institute of Medical Research, Darlinghurst, NSW, Australia, NHMRC Clinical Trials Centre, The University of Sydney, Princess Margaret Cancer Centre,